Vascular endothelial growth factor-C: A growth factor for lymphatic and blood vascular endothelial cells

Trends in Cardiovascular Medicine

Volumn 8, Issue 7, 1998, Pages 292-297

  Enholm, Berndt ^a   Jussila, Lotta ^a   Karkkainen, Marika ^a   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; VASCULOTROPIN;

ANGIOGENESIS; ATHEROGENESIS; BLOOD VESSEL TONE; CARCINOGENESIS; ENDOTHELIUM CELL; HUMAN; LYMPH VESSEL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0032192493     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00026-7     Document Type: Article

References (33)

1. Achen M.G., Jeltsch M., Kukk E.et al. Vascular endothelial growth factor-D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor-2 (Flk1) and VEGF receptor-3 (Flt4). Proc Natl Acad Sci USA. 95:1997;548-553.
2. Aselli G. De Lactibus sive Lacteis Venis, Quarto Vasorum Mesarai corum Gernere novo invento. 1627;Italy, J, Milan. B. Biddelium, Mediolani.
3. Cao Y., Chen H., Zhou L.et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. J Biol Chem. 271:1996;3154-3162.
4. Chilov D., Kukk E., Taira S.et al. Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem. 272:1997;25,176-25,183.
5. Enholm B., Paavonen K., Ristimaki A.et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene. 14:1997;2475-2483.
6. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 18:1997;4-25.
7. Goldberg I.M., Rosen E.M. Regulation of Angiogenesis. 1997;Switzerland, Birkenhäuser Verlag, Basel.
8. Grimmond S., Lagercrantz J., Drinkwater C.et al. Cloning and characterisation of a novel human gene related to vascular endothelial growth factor. Genome Res. 6:1996;124-131.
9. Hu J.S., Hastings G.A., Cherry S., Gentz R., Ruben S., Coleman T.A. A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells. FASEB J. 11:1997;498-504.
10. Jain R.K. 1996 Landis Award Lecture. delivery of molecular and cellular medicine to solid tumors Microcirculation. 4:1997;1-23.
11. Jeltsch M., Kaipainen A., Joukov V.et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 276:1997;1423-1425.
12. Joukov V., Pajusola K., Kaipainen A.et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:1996;290-298.
13. Joukov V., Sorsa T., Kumar V.et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16:1997;3898-3911.
14. Jussila L., Valtola R., Partanen T.et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58:1998;1599-1604.
15. Kaipainen A., Korhonen J., Mustonen T.et al. Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to endothelium of lymphatic vessels during development. Proc Natl Acad Sci USA. 92:1995;3566-3570.
16. Keyt B.A., Nguyen H.V., Berleau L.T.et al. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. J Biol Chem. 271:1996;5638-5646.
17. Kukk E., Lymboussaki A., Taira S.et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggest a role in lymphatic vascular development. Development. 122:1996;3829-3837.
18. Leak L.V. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc Res. 2:1970;361-391.
19. Lee J., Gray A., Yuan J., Louth S.-M., Avraham H., Wood W. Vascular endothelial growth factor-related protein. a ligand and specific activator of the tyrosine kinase receptor Flt4 Proc Natl Acad Sci USA. 93:1996;1988-1992.
20. Lyttle D.J., Fraser K.M., Fleming S.B., Mercer A.A., Robinson A.J. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol. 68:1994;84-92.
21. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA. 88:1991;9267-9271.
22. Ogawa S., Oku A., Sawano A.et al. A novel type of vascular endothelial growth factor. VEGF-E (NZ-7 VEGF) preferentially utilizes KDR/FIK-1 receptor and carries a potent mitogenic activity without heparin-binding domain Proc Natl Acad Sci. in press:1998.
23. Oh S.-J., Jeltsch M.M., Birkenhäger R.et al. VEGF and VEGF-C. specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane Dev Biol. 188:1998;96-109.
24. Olofsson B., Pajusola K., von Euler G., Chilov D., Alitalo K., Eriksson U. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem. 271:1996;19,310-19,317.
25. Orlandini M., Marconcini L., Ferruzzi R., Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA. 93:1996;11,675-11,680.
26. Paavonen K., Horelli-Kuitunen N., Chilov D.et al. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation. 93:1996;1079-1082.
27. Pajusola K., Aprelikova O., Pelicci G., Weich H., Claesson-Welsh L., Alitalo K. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene. 9:1994;3545-3555.
28. Pepper M.S., Mandriota S.J., Jeltsch M.et al. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J Cell Physiol. in press:1998.
29. Ristimäki A., Narko K., Enholm B., Alitalo K. Proinflammatory cytokines regulate expression of the lymphatic vessel-specific growth factor VEGF-C. J Biol Chem. 273:1998;8413-8418.
30. Sabin F.R. On the origin and development of the lymphatic system from the veins and the development of the lymph hearts and the thoracic duct in the pig. Am J Anat. 1:1902;367-389.
31. Starling E.H. Physiologic factors involved in the causation of dropsy. Lancet. 1:1896;1267-1270.
32. Witzenbichler B., Aschara T., Munhara T.et al. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol. 153:1998;381-394.
33. Yamada Y., Nezu J., Shimane M., Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 42:1997;483-488.